Online inquiry

IVTScrip™ mRNA-Human AAMDC, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK11115MR)

This product GTTS-WK11115MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the AAMDC protein. This product can be used in Retinoid acid signaling-responsive fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001316957.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 28971
UniProt ID Q9H7C9
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AAMDC, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK11115MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK19414MR IVTScrip™ mRNA-Human ANKRD28, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD28
GTTS-WK11595MR IVTScrip™ mRNA-Human ADAM33, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADAM33
GTTS-WK26708MR IVTScrip™ mRNA-Human APH1B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA APH1B
GTTS-WK14184MR IVTScrip™ mRNA-Human ABTB1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABTB1
GTTS-WK18505MR IVTScrip™ mRNA-Human ANKRD18DP, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD18DP
GTTS-WK19713MR IVTScrip™ mRNA-Human ANKRD27, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD27
GTTS-WK9397MR IVTScrip™ mRNA-Human AC133, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AC133
GTTS-WK27305MR IVTScrip™ mRNA-Human Apelin, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Apelin
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW